GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages.

Authors:
Zhang Q; Chen LH; Yang H; Fang YC; Wang SW and 7 more

Journal:
Acta Pharmacol Sin

Publication Year: 2021

DOI:
10.1038/s41401-021-00825-y

PMCID:
PMC9343429

PMID:
34912006

Journal Information

Full Title: Acta Pharmacol Sin

Abbreviation: Acta Pharmacol Sin

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interest."

Evidence found in paper:

"This work was supported by Grants from the National Natural Science Foundation of China (81730099, 82121005, and 22077132), Shanghai Science and Technology Commission (20S11903200, 20ZR1471200, and 19ZR1411600), the “Personalized Medicines—Molecular Signature-based Drug Discovery and Development,” Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12020229), National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program,” China (2018ZX09711002-002), and Youth Innovation Promotion Association of the Chinese Academy of Sciences grants (2020283 and 2017329)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025